Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-Dose Ceftriaxone for Bacterial Meningitis and Optimization of Administration Scheme Based on Nomogram.
Grégoire M, Dailly E, Le Turnier P, Garot D, Guimard T, Bernard L, Tattevin P, Vandamme YM, Hoff J, Lemaitre F, Verdier MC, Deslandes G, Bellouard R, Sébille V, Chiffoleau A, Boutoille D, Navas D, Asseray N. Grégoire M, et al. Among authors: guimard t. Antimicrob Agents Chemother. 2019 Aug 23;63(9):e00634-19. doi: 10.1128/AAC.00634-19. Print 2019 Sep. Antimicrob Agents Chemother. 2019. PMID: 31235630 Free PMC article. Clinical Trial.
Risk factors for prolonged treatment of lymph node tuberculosis.
Lanoix JP, Guimard T, Ettahar N, Grannec A, Flateau C, Chapuzet C, Bentayeb H, Tattevin P, Schmit JL. Lanoix JP, et al. Among authors: guimard t. Int J Tuberc Lung Dis. 2012;16(3):373-5. doi: 10.5588/ijtld.11.0470. Epub 2012 Jan 5. Int J Tuberc Lung Dis. 2012. PMID: 22230257
Erratum to 'Predominance of healthcare-associated cases among episodes of community-onset bacteraemia due to extended-spectrum β-lactamase-producing Enterobacteriaceae' [International Journal of Antimicrobial Agents 49/1 67-73].
Zahar JR, Lesprit P, Ruckly S, Eden A, Hikombo H, Bernard L, Harbarth S, Timsit JF, Brun-Buisson C; BacterCom Study Group. Zahar JR, et al. Int J Antimicrob Agents. 2017 Apr;49(4):480-481. doi: 10.1016/j.ijantimicag.2017.02.007. Epub 2017 Mar 6. Int J Antimicrob Agents. 2017. PMID: 28279672 Free article. No abstract available.
Switching from abacavir/lamivudine plus nevirapine to abacavir/lamivudine/dolutegravir in virologically controlled HIV-infected adults (SWAD study).
Allavena C, Volteau C, André-Garnier E, Guimard T, Hall N, Khatchatourian L, Morrier M, Billaud E, Rodallec A, Reliquet V, Jovelin T, Le Guen L, Perré P, Grégoire M, Raffi F. Allavena C, et al. Among authors: guimard t. Med Mal Infect. 2019 Oct;49(7):505-510. doi: 10.1016/j.medmal.2018.11.012. Epub 2018 Dec 21. Med Mal Infect. 2019. PMID: 30583867
Tolerability of high-dose ceftriaxone in CNS infections: a prospective multicentre cohort study.
Le Turnier P, Navas D, Garot D, Guimard T, Bernard L, Tattevin P, Vandamme YM, Hoff J, Chiffoleau A, Dary M, Leclair-Visonneau L, Grégoire M, Pere M, Boutoille D, Sébille V, Dailly E, Asseray N; High-Dose Ceftriaxone CNS Infections Study Group. Le Turnier P, et al. Among authors: guimard t. J Antimicrob Chemother. 2019 Apr 1;74(4):1078-1085. doi: 10.1093/jac/dky553. J Antimicrob Chemother. 2019. PMID: 30698733 Clinical Trial.
102 results